State Street Health Care Select Sector SPDR ETF XLV
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.08%
- Net assets
- $40.6B
- Holdings
- 65
- 12-month distribution yield
- 1.42%
- Asset class
- Equity
State Street Health Care Select Sector SPDR ETF (XLV) is an exchange-traded fund listed on NYSE Arca in the United States, issued by State Street. Its category is Equity · US (equity). Its last price was US$179.82 on 20 Oct 2026. Its expense ratio is 0.08% a year, from its prospectus dated 31 Jan 2026. It reported net assets of US$40.6 billion as of 30 Jun 2026. Its latest holdings report lists 65 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$2.55 a unit, a 12-month distribution yield of 1.42%, paid quarterly.
Fees
- Total annual operating expenses (gross)
- 0.08%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.03%
- Prospectus date
- 31 Jan 2026
- Filed with the SEC
- 28 Jan 2026
Size and reporting
- Net assets
- $40,598,944,976
- Total assets
- $40,609,814,997
- Holdings as of
- 30 Jun 2026
- Report made public
- 28 Aug 2026 (59 days after the month end)
Top holdings
Largest 25 of 65 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 16.51% | $6.7B | Equity (common) | United States | USD |
| 2 | Johnson & Johnson | US4781601046 | 10.64% | $4.3B | Equity (common) | United States | USD |
| 3 | AbbVie Inc | US00287Y1091 | 7.74% | $3.1B | Equity (common) | United States | USD |
| 4 | UnitedHealth Group Inc | US91324P1021 | 6.57% | $2.7B | Equity (common) | United States | USD |
| 5 | Merck & Co Inc | US58933Y1055 | 5.52% | $2.2B | Equity (common) | United States | USD |
| 6 | Amgen Inc | US0311621009 | 3.40% | $1.4B | Equity (common) | United States | USD |
| 7 | Thermo Fisher Scientific Inc | US8835561023 | 3.24% | $1.3B | Equity (common) | United States | USD |
| 8 | Abbott Laboratories | US0028241000 | 2.75% | $1.1B | Equity (common) | United States | USD |
| 9 | Gilead Sciences Inc | US3755581036 | 2.73% | $1.1B | Equity (common) | United States | USD |
| 10 | Intuitive Surgical Inc | US46120E6023 | 2.45% | $995.0M | Equity (common) | United States | USD |
| 11 | Pfizer Inc | US7170811035 | 2.39% | $969.6M | Equity (common) | United States | USD |
| 12 | CVS Health Corp | US1266501006 | 2.30% | $932.5M | Equity (common) | United States | USD |
| 13 | Vertex Pharmaceuticals Inc | US92532F1003 | 2.19% | $890.7M | Equity (common) | United States | USD |
| 14 | Danaher Corp | US2358511028 | 2.09% | $847.7M | Equity (common) | United States | USD |
| 15 | Bristol-Myers Squibb Co | US1101221083 | 2.05% | $831.3M | Equity (common) | United States | USD |
| 16 | Stryker Corp | US8636671013 | 1.89% | $767.4M | Equity (common) | United States | USD |
| 17 | Medtronic PLC | IE00BTN1Y115 | 1.75% | $709.6M | Equity (common) | Ireland | USD |
| 18 | McKesson Corp | US58155Q1031 | 1.58% | $641.7M | Equity (common) | United States | USD |
| 19 | Elevance Health Inc | US0367521038 | 1.46% | $593.3M | Equity (common) | United States | USD |
| 20 | Cigna Group/The | US1255231003 | 1.27% | $515.2M | Equity (common) | United States | USD |
| 21 | Boston Scientific Corp | US1011371077 | 1.10% | $448.2M | Equity (common) | United States | USD |
| 22 | Regeneron Pharmaceuticals Inc | US75886F1075 | 1.08% | $440.2M | Equity (common) | United States | USD |
| 23 | HCA Healthcare Inc | US40412C1018 | 1.05% | $427.7M | Equity (common) | United States | USD |
| 24 | Cardinal Health Inc | US14149Y1082 | 0.97% | $393.1M | Equity (common) | United States | USD |
| 25 | Cencora Inc | US03073E1055 | 0.96% | $388.9M | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.68% | |
| Short-term investment vehicles (cash funds) | 0.26% | |
| Equity derivatives | <0.01% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 97.85% | |
| Ireland | 2.11% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 99.95% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 87.53% | |
| Industrials | 7.29% | |
| Consumer Staples | 2.30% | |
| Technology | 0.46% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $2.5500
- 12-month yield
- 1.42%
- Frequency
- Quarterly
- Latest ex-date
- 21 Sep 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($2.5500) ÷ latest price ($179.82) × 100 = 1.42%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (20 payments)
| Ex-date | Amount per unit |
|---|---|
| 21 Sep 2026 | $0.6420 |
| 22 Jun 2026 | $0.6560 |
| 23 Mar 2026 | $0.5950 |
| 22 Dec 2025 | $0.6570 |
| 22 Sep 2025 | $0.6250 |
| 23 Jun 2025 | $0.6300 |
| 24 Mar 2025 | $0.5650 |
| 23 Dec 2024 | $0.6220 |
| 23 Sep 2024 | $0.5770 |
| 24 Jun 2024 | $0.5730 |
| 18 Mar 2024 | $0.5230 |
| 18 Dec 2023 | $0.5980 |
| 18 Sep 2023 | $0.5400 |
| 20 Jun 2023 | $0.5420 |
| 20 Mar 2023 | $0.4890 |
| 19 Dec 2022 | $0.5560 |
| 19 Sep 2022 | $0.5060 |
| 21 Jun 2022 | $0.5040 |
| 21 Mar 2022 | $0.4260 |
| 20 Dec 2021 | $0.5280 |
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000006412) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- XLV and VTI Vanguard Morningstar Total Stock Market ETF
- XLV and VOO Vanguard S&P 500 ETF
- XLV and IVV iShares Core S&P 500 ETF
- XLV and QQQ Invesco QQQ Trust, Series 1